The Study of MicroRNA Genomics of Blood Stasis Syndrome and of Coronary Heart Disease
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01615003|
Recruitment Status : Unknown
Verified January 2014 by Guang'anmen Hospital of China Academy of Chinese Medical Sciences.
Recruitment status was: Recruiting
First Posted : June 8, 2012
Last Update Posted : January 14, 2014
|Condition or disease||Intervention/treatment||Phase|
|Coronary Heart Disease Unstable Angina Blood Stasis Syndrome||Drug: Xuesaitong soft capsule Drug: Xuesaitong soft capsule Placebo||Phase 2|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||70 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|
|Official Title:||The Analysis of Blood Stasis Syndromeand of Coronary Heart Disease Related MicroRNA Genomics and Target Gene Regulatory Networks|
|Study Start Date :||May 2012|
|Estimated Primary Completion Date :||July 2014|
|Estimated Study Completion Date :||December 2014|
Experimental: Xuesaitong soft capsule group
Patients who confirmed by coronary angiography and diagnosed blood stasis syndrome of coronary heart disease are given conventional Western medicine treatment and Xuesaitong soft capsule.
Drug: Xuesaitong soft capsule
Xuesaitong soft capsule, soft capsule, Ingredients:PNS, Specification:0.33 per bag, once take two pills and twice a day during a month.
Placebo Comparator: control group
Patients who confirmed by coronary angiography and diagnosed blood stasis syndrome of coronary heart disease are given conventional Western medicine treatment and placebo.
Drug: Xuesaitong soft capsule Placebo
Xuesaitong soft capsule Placebo, soft capsule, once take two pills and twice a day during a month.
- the change of Cycle threshold of relational microRNA in coronary artery disease with unstable angina [ Time Frame: 1 month ]The change of Cycle threshold of relational microRNA in coronary artery disease with unstable angina by real RT-PCR.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01615003
|Contact: Fei Teng, email@example.com|
|Guang'an men Hispital||Recruiting|
|Beijing, Beijing, China, 100000|
|Contact: Fei Teng, master 13581985462 firstname.lastname@example.org|
|Contact: Gui Yu, master 13488835663|
|Principal Investigator: Jie Wang, doctor|